Delivery Order SPE2DB20D2104-SPE2DB23FU00X
- Not listed
- This federal contract award is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdose, to the Defense Logistics Agency (DLA). The $7,940.14 delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on May 10, 2023, with a completion date of May 11, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which holds a substantial Indefinite Delivery Contract (IDC) valued at up to...
- This federal contract award is for the delivery of NARCAN 4 mg nasal spray to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $2,344.97, is a firm fixed-price delivery order with a completion date of January 30, 2023. There is no set-aside designation for this contract. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc.,...
- This federal contract award is for the delivery of NARCAN 4 MG NASAL SPRAY 2S to the Defense Logistics Agency (DLA). The contract, valued at $1,951.13, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of April 26, 2024 and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical opioid overdose reversal medication, to the Defense Logistics Agency (DLA). The $1,459.58 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on April 30, 2024, with a completion date of May 1, 2024. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with...
- This federal contract award is a delivery order (SPE2DB23FP76X) issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used for opioid overdose reversal. The contract has a firm fixed price of $8,758.69 and a completion date of August 21, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora,...
- This federal contract award is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdoses, to the Defense Logistics Agency (DLA). The $10,397.54 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with no set-aside designation. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the...
- This federal contract award is for the delivery of NARCAN 4 MG NASAL SPRAY 2S to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,803.69 and an ultimate completion date of April 15, 2024. It is a firm-fixed-price delivery order contract with no set-aside designation, indicating open...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,623.05 Firm Fixed Price Delivery Order is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used for the treatment of opioid overdose. The contract has an ultimate completion date of April 19, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,854.24, is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used for opioid overdose reversal. The contract is a Firm Fixed Price Delivery Order with a completion date of November 21, 2023. Amerisourcebergen holds a larger Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,616.72, is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used for the treatment of opioid overdose. This is a Firm Fixed Price Delivery Order contract with a completion date of September 19, 2023. Amerisourcebergen Drug Corp is a subsidiary of...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FU00XDelivery Order
This federal contract award is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical emergency medication used to treat opioid overdoses, to the Defense Logistics Agency (DLA). The contract, valued at $2,271.68, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of June 16, 2023 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical for a comprehensive range of pharmaceutical products and medical supplies. This IDC serves as the primary vehicle for Amerisourcebergen to deliver essential medications and medical commodities to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 6/15/23 |